ANURAS Share Price Performance
₹1,252.50
481.85 (62.53%)
100.4% overvalued intrinsic discount
₹625.00
Fair Value
Price ₹1,252.50
AnalystLowTarget ₹625.00
AnalystConsensusTarget ₹922.14
AnalystHighTarget ₹1,667.80
Fair Value₹625.00
Share Pricen/a
Anupam Rasayan India Ltd Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
ANURAS Community Narratives
AN
Fair Value ₹625 100.4% overvalued intrinsic discount
US Tariffs And Global Green Trends Will Compress Margins
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value ₹922.14 35.8% overvalued intrinsic discount
ANURAS: Slowing Revenue Expansion Will Pressure Margins Despite Profit Recovery
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value ₹1.67k 24.9% undervalued intrinsic discount
Green Specialty Chemical Trends And China+1 Shifts Will Spark Expansion
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Green Specialty Chemical Trends And China+1 Shifts Will Spark Expansion
Key Takeaways Rapid revenue growth, improved margins, and strong cash flows are driving outperformance, with operational efficiencies accelerating earnings and capital returns faster than analyst expectations. Strategic positioning in innovative chemistries, export-oriented partnerships, and automation efforts establish long-term market leadership and sustained premium growth opportunities.Read more
8
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
₹1.67k
24.9% undervalued intrinsic discount
Fair Value
Revenue
17.48% p.a.
Profit Margin
13.72%
Future PE
61.51x
Price in 2029
₹2.42k
US Tariffs And Global Green Trends Will Compress Margins
Key Takeaways Global regulatory pressures, green chemistry trends, and intense Asian competition threaten export growth, pricing power, and margins for traditional specialty chemicals. Heavy dependence on a handful of key customers and volatile input costs amplify earnings risks and undermine the stability of long-term profit levels.Read more
15
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
₹625
100.4% overvalued intrinsic discount
Fair Value
Revenue
5.58% p.a.
Profit Margin
12.02%
Future PE
37.47x
Price in 2029
₹913.22
ANURAS: Slowing Revenue Expansion Will Pressure Margins Despite Profit Recovery
Key Takeaways Elevated growth expectations are supported by robust custom synthesis agreements, but heavy client concentration increases vulnerability to contract shifts and global market volatility. Regulatory, supply chain, and industry consolidation pressures could squeeze margins and require costly product or process adaptations amid changing global chemistry standards.Read more
26
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
₹922.14
35.8% overvalued intrinsic discount
Fair Value
Revenue
13.1% p.a.
Profit Margin
12.66%
Future PE
43x
Price in 2029
₹1.36k
Trending Discussion
Recently Updated Narratives
AN
ANURAS: Overseas Acquisitions And Expanded Borrowing Capacity Will Drive Future Upside
Fair Value: ₹1.67k 24.9% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
ANURAS: Planned Acquisition And Higher Leverage Will Sustain An Unfavorable Risk Profile
Fair Value: ₹625 100.4% overvalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
ANURAS: Planned Acquisition And Higher Leverage Will Pressure Sentiment Through 2026
Fair Value: ₹922.14 35.8% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Anupam Rasayan India Ltd Key Details
About ANURAS
- Founded
- 1984
- Employees
- 2606
- CEO
- WebsiteView website
Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients. It provides other specialty chemicals used in various end-user segments, including specialty pigments, specialty dyes, and polymer additives. The company was incorporated in 1984 and is headquartered in Surat, India.
